Smith+Nephew Launches CARTIHEAL Implant Across Key European MarketsZacks Investment Research · Oct 8, 2026
Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de PortugalGlobeNewsWire · Oct 6, 2026
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l'innovativo impianto per la riparazione della cartilagine, che sarà presentato all'ICRS Summit in Portogallo.GlobeNewsWire · Oct 6, 2026
Smith+Nephew's revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in PortugalGlobeNewsWire · Oct 6, 2026
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma CareZacks Investment Research · Sep 30, 2026
Smith & Nephew SNATS (NYSE:SNN) Reaches New 52-Week Low – Time to Sell?Defense World · Sep 25, 2026Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $0.94 | $0.95 | Beat |
| Mar 2, 2026 | $1.16 | $1.18 | Beat |
| Aug 5, 2025 | $0.79 | $0.86 | Beat |
| Feb 25, 2025 | $0.92 | $0.94 | Beat |
| Oct 31, 2024 | $0.80 | $0.50 | Miss |
| Aug 1, 2024 | $0.79 | $0.75 | Miss |